Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis

Annals of Neurology

Volumn 71, Issue 5, 2012, Pages 601-613

  Dhaunchak, Ajit Singh ^a,b   Becker, Christopher ^c   Schulman, Howard ^c   De Faria Jr , Omar ^a,b   Rajasekharan, Sathyanath ^a   Banwell, Brenda ^d   Colman, David R ^a,b   Bar Or, Amit ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Pharmaceutical Product Development   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLPHOSPHATASE 2; ANKYRIN B; ANKYRIN G; APOLIPOPROTEIN C2; AXONIN 1; BREVICAN; CARBOXYPEPTIDASE E PREPROPROTEIN; CATHEPSIN H; CD163 ANTIGEN; COLLAGEN TYPE 6; CONTACTIN 1; CYTOKERATIN 16; DIPEPTIDYL PEPTIDASE 7 PREPROPROTEIN; FIBULIN 1; FRUCTOSE BISPHOSPHATE ALDOLASE A; GLIOMEDIN; GROWTH ASSOCIATED PROTEIN 43 ISOFORM 1; HERMES ANTIGEN; JUNCTIONAL ADHESION MOLECULE 2 PRECURSOR; LEUCINE RICH REPEAT CONTAINING 4B; MYELIN; PROTEIN; PROTEIN S; REELIN B; SECRETED FRIZZLED RELATED PROTEIN 4; SULFATASE 2 ISOFORM B PRECURSOR; TENASCIN R; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIPEPTIDYL PEPTIDASE I PREPROPROTEIN; UNCLASSIFIED DRUG; VERSICAN;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; CELL INTERACTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GLIA; HUMAN; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROLOGIC EXAMINATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SCHOOL CHILD; UPREGULATION;

AUTOANTIGENS; AXONS; BIOLOGICAL MARKERS; CHILD; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; MYELIN PROTEINS; NERVE TISSUE PROTEINS; NEUROGLIA; RANVIER'S NODES;

EID: 84860219699     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22693     Document Type: Article

References (30)

1. Trapp BD, Nave KA,. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008; 31: 247-269.
2. Lassmann H,. Experimental autoimmune encephalomyelitis. In:, Robert AL, Griffin JW, Lassman H, Nave KA, Miller R, Trapp BD. Myelin biology and disorders. San Diego, CA: Academic Press, 2004: 1039-1071.
3. Tumani H, Hartung HP, Hemmer B, et al. Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis 2009; 35: 117-127.
4. Awad A, Hemmer B, Hartung HP, et al. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol 2010; 219: 1-7.
5. Ghezzi A,. Clinical characteristics of multiple sclerosis with early onset. Neurol Sci 2004; 25 (suppl 4): S336-S339.
6. Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6: 887-902.
7. Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011; 10: 436-445.
8. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005; 58: 840-846.
9. Wang W, Zhou H, Lin H, et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem 2003; 75: 4818-4826.
10. Krokhin OV, Craig R, Spicer V, et al. An improved model for prediction of retention times of tryptic peptides in ion pair reversed-phase HPLC: its application to protein peptide mapping by off-line HPLC-MALDI MS. Mol Cell Proteomics 2004; 3: 908-919.
11. Becker CH, Kumar P, Jones T, Lin H,. Nonparametric mass calibration using hundreds of internal calibrants. Anal Chem 2007; 79: 1702-1707.
12. Tait S, Gunn-Moore F, Collinson JM, et al. An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol 2000; 150: 657-666.
13. Bernier L, Alvarez F, Norgard EM, et al. Molecular cloning of a 2',3'-cyclic nucleotide 3'-phosphodiesterase: mRNAs with different 5' ends encode the same set of proteins in nervous and lymphoid tissues. J Neurosci 1987; 7: 2703-2710.
14. Salzer JL, Holmes WP, Colman DR,. The amino acid sequences of the myelin-associated glycoproteins: homology to the immunoglobulin gene superfamily. J Cell Biol 1987; 104: 957-965.
15. Pedraza L, Fidler L, Staugaitis SM, Colman DR,. The active transport of myelin basic protein into the nucleus suggests a regulatory role in myelination. Neuron 1997; 18: 579-589.
16. Dhaunchak AS, Nave KA,. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc Natl Acad Sci U S A 2007; 104: 17813-17818.
17. Dhaunchak AS, Huang JK, De Faria O Jr, et al. A proteome map of axoglial specializations isolated and purified from human central nervous system. Glia 2010; 58: 1949-1960.
18. Susuki K, Rasband MN,. Molecular mechanisms of node of Ranvier formation. Curr Opin Cell Biol 2008; 20: 616-623.
19. Huang JK, Phillips GR, Roth AD, et al. Glial membranes at the node of Ranvier prevent neurite outgrowth. Science 2005; 310: 1813-1817.
20. Neuteboom RF, Boon M, Catsman Berrevoets CE, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008; 71: 967-973.
21. Chiasserini D, Di Filippo M, Candeliere A, et al. CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. Eur J Neurol 2008; 15: 998-1001.
22. Nie DY, Ma QH, Law JW, et al. Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule OMgp. Neuron Glia Biol 2006; 2: 151-164.
23. Feinberg K, Eshed-Eisenbach Y, Frechter S, et al. A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier. Neuron 2010; 65: 490-502.
24. Zonta B, Tait S, Melrose S, et al. Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system. J Cell Biol 2008; 181: 1169-1177.
25. Derfuss T, Parikh K, Velhin S, et al. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc Natl Acad Sci U S A 2009; 106: 8302-8307.
26. Mathey EK, Derfuss T, Storch MK, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007; 204: 2363-2372.
27. Howell OW, Palser A, Polito A, et al. Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 2006; 129 (pt 12): 3173-3185.
28. Rothbard JB, Zhao X, Sharpe O, et al. Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis. J Immunol 2011; 186: 4263-4268.
29. van Noort JM, Bsibsi M, Gerritsen WH, et al. Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol 2010; 69: 694-703.
30. Krupp LB, Banwell B, Tenembaum S,. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7-S12.